Xenon Pharmaceuticals announces at-the-market equity offering
Xenon Pharma announced it has entered into an at-the-market equity offering sales agreement with Jefferies and Stifel, effective July 11, 2018, under which Xenon may sell its common shares, from time to time, for up to $50.0 million in aggregate sales proceeds in "at the market" transactions. July 12, 2018